Yourwellness Magazine Follows Up New NICE Hepatitis C Treatment Recommendation
London, UK (PRWEB UK) 18 August 2013
In draft guidance published on the 18th of June, NICE recommended peginterferon alfa in combination with ribavirin as an option for treating chronic hepatitis C in children and young people. Professor Carole Longson, NICE Health Technology Evaluation Centre Director, commented, “The independent Appraisal Committee concluded that treatment with peginterferon alfa and ribavirin can decrease the hepatitis C virus to undetectable levels, effectively providing the equivalent of a cure for the disease. By widening access to these drugs this guidance will give clinicians and people living with hepatitis C more treatment options. Early successful treatment is also likely to lessen the social stigma that can be associated with hepatitis C infection later in life.” (http://www.nice.org.uk/newsroom/pressreleases/NICEDraftGuidanceRecommendsDrugsToTreatChronicHepatitisCInChildrenAndYoungPeople.jsp)
With this in mind, Yourwellness Magazine took a closer look at the causes, symptoms and treatment of hepatitis C. According to Yourwellness Magazine, “As many as one in 40 people carry the hep C virus, yet many are unaware they are infected. As a result, chronic hep C is the most common reason for needing a liver transplant, even though the infection is curable if diagnosed at an early stage.” (http://www.yourwellness.com/2012/01/could-you-have-hepatitis-c/#sthash.HnOq1u9T.dpuf)
Yourwellness Magazine outlined the causes, symptoms and treatment of hepatitis C:
Causes – The main routes of infection are sharing drug injection equipment, receiving medical or dental treatment abroad in countries where hepatitis C is common and equipment is not sterilised properly, unprotected sex, sharing a razor or toothbrush with someone who has hepatitis C, and from mother to baby during childbirth.
Symptoms – Most people who carry the hepatitis C virus have no signs or symptoms, but some develop fatigue, aches and pains, a mild flu-like illness with jaundice, and even progressive liver damage if the infection goes untreated.
Treatment – Antiviral drugs such as interferon, ribavirin and amantadine (triple therapy) may be suggested for people with chronic hepatitis C, as well as hepatitis A and B vaccinations.